Results 111 to 120 of about 52,744 (222)

Sequential and Concurrent C5 and Neonatal Fc Receptor Inhibition in Prolonged Myasthenic Crisis due to Advanced Invasive Thymoma‐Associated Myasthenia Gravis: A Case Report and Literature Review

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Thymoma‐associated myasthenia gravis (TAMG) is frequently refractory, particularly when complicated by myasthenic crisis in advanced invasive disease. Complement C5 inhibitors and neonatal Fc receptor (FcRn) inhibitors have expanded the treatment of acetylcholine receptor (AChR) antibody‐positive generalized myasthenia gravis; however, their ...
Yuta Kizuka, Yuriko Nakamura, Kensuke Okada, Yu Okubo, Kaoru Kaseda, Hirofumi Toyama, Keisuke Asakura, Atsuya Takeda, Jin Nakahara, Kei Ishizuchi   +9 more
wiley   +1 more source

Mapping of C5‐Blocking Monoclonal Antibodies Reveals New C5 Inhibitory Epitopes and Novel Modes of C5 Inhibition

Immunology, Volume 179, Issue 3, Page 444-456, November 2026.
We identify four distinct C5 inhibitory epitopes, including two novel antibodies that selectively block membrane attack complex (MAC) assembly while preserving C5 cleavage and C5a generation. These findings establish selective MAC inhibition as a new therapeutic strategy for complement‐mediated diseases.
Rebekah Sian Cooke, Kok Yung Lee, Georgina Elizabeth Menzies, Masashi Mizuno, Bryan Paul Morgan, Wioleta Milena Zelek   +5 more
wiley   +1 more source

Investigating the Risk Factors for Medication Nonadherence in Myasthenia Gravis Patients: Establishing a Nomogram Model

Patient Preference and Adherence
Chaoying Liu,1– 3 Simei Ning,1 Ping Lu,1,2 Wenli Jia,1 Xiaohe Zhang,1– 3 Guoyan Qi1– 31Treatment Center of Myasthenia Gravis, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Hebei Provincial Key Laboratory of Myasthenia ...
Liu C, Ning S, Lu P, Jia W, Zhang X, Qi G   +5 more
doaj  

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis

Revista Brasileira de Anestesiologia
Myasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fluctuates, worsening with exertion, and improving with rest. Diagnosis of myasthenia gravis is made following clinical and physical examination and is confirmed by
Lokman Soyoral, Ugur Goktas, Muhammed Bilal Cegin, Volkan Baydi   +3 more
doaj   +1 more source

Myasthenia Gravis (Russian)

, 2008
A patient brochure on myasthenia ...
NANOS
core  

Bottom‐Up Engineering of a Human Neuromuscular System for Modeling Activity‐Induced Remodeling, Metabolic Stress, and Endothelial‐Modulated Excitability

Advanced Materials, Volume 38, Issue 60, 27 October 2026.
Using a bottom‐up approach, we engineered a human neuromuscular microchip to investigate distinct adaptive responses to neural stimulation and metabolic stress. Further integration of endothelial cells revealed their critical role in modulating neuromuscular excitability, establishing a comprehensive neurovascular‐muscular model.
Jinchul Ahn, Min‐seop Kim, Ju‐Hee Kim, Seok‐Hyeon Kang, Dain Lee, Hui‐Wen Liu, Seung‐cheol Shin, Kyuhwan Na, Yesl Jun, Oak‐Kee Hong, Ji Hun Yang, Jin‐A Kim, Hwanseok Jang, Hong Nam Kim, Roger D. Kamm, Ji‐Hoon Kim, Jang‐Won Son, Seok Chung   +17 more
wiley   +1 more source

Ocular Myasthenia Gravis

, 2019
Dr.
Andrew G. Lee, MD; Pauline Berens
core  

Defining Features of Gabriele‐de Vries Syndrome in Adults: A Case Report and Literature Review

American Journal of Medical Genetics Part A, Volume 200, Issue 10, Page 2396-2404, October 2026.
ABSTRACT Gabriele‐de Vries syndrome (GADEVS) is a neurodevelopmental disorder caused by heterozygous pathogenic variants in the YY1 gene. Like most rare genetic syndromes, the adult manifestations of GADEVS remain poorly defined. Here, we describe the oldest patient reported to date with GADEVS—a 63‐year‐old woman with a c.1177_1179del YY1 variant ...
Ethan W. Hollingsworth, Changrui Xiao
wiley   +1 more source

The Effect of Medication Beliefs on Medication Adherence in Patients with Myasthenia Gravis: The Mediating Roles of Self-Efficacy and Illness Perception

Patient Preference and Adherence
Chaoying Liu,1– 3 Wenli Jia,1 Ping Lu,1 Simei Ning,1 Guoyan Qi1– 31Treatment Center of Myasthenia Gravis, Shijiazhuang People’s Hospital, Shijiazhuang, Hebei, People’s Republic of China; 2Hebei Provincial Key ...
Liu C, Jia W, Lu P, Ning S, Qi G
doaj  

Neoplasia Associated Ocular Myasthenia Gravis: Primary Renal Tumor in Two Patients with Newly Diagnosed Ocular Myasthenia Gravis

, 2006
Poster, "Neoplasia Associated Ocular Myasthenia Gravis: Primary Renal Tumor in Two Patients with Newly Diagnosed Ocular Myasthenia ...
Susan Andracchi
core